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Summary. The use of specific anti-fsh and anti-lh substances has
shown that lh is the only pituitary gonadotrophin involved in the
implantation process. Using different dosages of lh antiserum at
different time intervals, it has been possible to arrive at a minimum
effective dose (0\m=.\05ml) which, when given on the 4th day at 10.00
hours, results in inhibition of implantation on the 8th day. We have
shown that, at this dose, the antiserum is mainly inhibiting the oestrogen
surge. It is proposed that an lh surge precedes an oestrogen surge on
Day 4 of pregnancy.
INTRODUCTION
It is well known that the two ovarian steroids, oestrogen and progesterone,
produced under the influence of the pituitary, are essential for bringing about
implantation of the fertilized ovum in the rat. Using specific antigonadotrophins
we have recently reported briefly on the specific involvement of pituitary lh
in the implantation process (Madhwa Raj, Sairam 8c Moudgal, 1967).
The present paper gives a detailed account of our work on the mode of
action of lh in the implantation of the rat blastocyst.
MATERIALS AND METHODS
Hormones
nih-lh-s9, bovine thyrotrophin (nih-tsh-b4) and ovine fsh (nih-
fsh-s3) used in this study were gifts of the Endocrine Study Section, National
Institutes of Health, U.S.A. Oestradiol-17ß was purchased from Sigma
Chemicals Company, U.S.A. The follicle stimulating hormone inhibitor was
extracted and purified from the urine of the bonnet monkey according to the
method of Sairam, Madhwa Raj & Moudgal (1966, 1968). Highly purified
ovine prolactin and bovine growth hormone (gh) were gifts from Professor
C. H. Li, University of California, San Francisco.
Immunization
Antiserum to ovine lh was produced in an adult albino female rabbit
according to the method of Moudgal & Li (1961). The antiserum was suitably
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absorbed with 1:10 diluted normal sheep serum, to remove antibodies for
nonspecific serum proteins. The completion of absorption and presence of
specific antibodies to lh were confirmed by using the agar gel double diffusion
technique, the details of which have been described earlier (Moudgal & Li,
1961).
Animals and general procedures
Albino adult female rats of the Institute colony weighing 120 to 160 g were
used. They were mated with males of proven fertility, and the day on which
vaginal smears showed the presence of spermatozoa was considered as Day 1
of pregnancy.
The hormones and specific antigonadotrophins were administered by the
subcutaneous route. Laparotomies were performed on the 8th and 15th days
and autopsy on the 20th day of pregnancy. At each laparotomy the nature
and number of implantation sites were noted. At autopsy the ovarian and
uterine weights, number of corpora lutea and nature and number of implanta¬
tion sites or growing foetuses were noted. In some cases the animals were left
for the full period of gestation and allowed to litter.
Histology
Tissues were fixed in Bouin's fluid for 24 hr, embedded in paraffin, sectioned
to 10 µ thickness and stained with haematoxylin and eosin.
RESULTS
Immunological characterization of LH antiserum
The earlier report of Moudgal & Li (1961) showing that antiserum to ovine
lh cross-reacts with rat pituitary lh was confirmed using both the agar gel
double diffusion and biological inhibition test. Ovine lh antiserum has earlier
been successfully used to neutralize the physiological effects of lh in the rat,
such as spermatogenesis (Hayashida, 1962a) and oestrous cycle (Young,
Nasser & Hayashida, 1963).
The absorbed antiserum to lh, in an Ouchterlony double diffusion test, did
not show any cross-reaction with ovine pituitary fsh, prolactin and bovine gh.
Bovine tsh, however, showed the presence of an antigen which completely
cross-reacted with ovine lh, showing that the tsh preparation used was con¬
taminated with lh and the antiserum did not contain TSH-specific antibodies(Plate 1). Since antibodies specific to bovine gh (Li, Moudgal, Trenkle,
Bourdel & Sadri, 1962), ovine prolactin (Hayashida, 1962b) and fsh (Ely,
Tuercke & Chen, 1966) have been shown not to cross-react with the respective
hormones of the rat, even the presence of contaminating antibodies in the
ovine lh antiserum should not be of any consequence. The absorbed antiserum
had approximately 1 -2 to 1 -5 mg of antibody/ml as determined by the quanti¬
tative precipitin test described previously (Moudgal & Li, 1961).
Biological characterization of FSH inhibitor
The fsh inhibitor isolated from the monkey urine has been shown to be
PLATE 1
Immunological specificity of lh antiserum. The central well contained rabbit antiserum
to ovine lh absorbed with normal sheep serum. The other wells, from the top in clock-wisedirection, contained ovine lh (30 /ig), bovine gh (50 /ig), bovine tsh (50 /ig), ovine lh(30 /ig), ovine prolactin (50 /ig) and ovine fsh (100 /ig).
(Facing p. 336)
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species nonspecific in its action, in that it was able to neutralize the biological
activity of fsh from a variety of species including that of the rat (Sairam et al.,
1968). The inhibitor, however, does not neutralize lh. Five hundred µg of
this inhibitor could neutralize the biological activity of 200 ^g of nih-fsh-s3
in the hcg augmentation assay. The total dose of 1-3 mg of inhibitor used in
the present investigation was sufficient to inhibit completely the activity of
endogenous fsh.
Specificity of LH in initiating implantation
Administration of specific antigonadotrophins, lh antiserum and fsh inhi¬
bitor, to pregnant rats from Days 1 to 7 of pregnancy showed that only the
former was effective in inhibiting implantation, thus indicating that only lh
was involved in this process (Table 1 ). Though ovarian weight and number of
Table 1
involvement of lh in implantation
Group
I
 
III
Treatment
Normal rabbit serum(control)
Monkey fsh inhibitor*
Total dose: 1-25 mg
lh antiserumf
Total dose: 1-5 ml
No.
of
rats
No. of
rats with
sites
Ave.
no. of
sites
8-6
10-0
0
Uterine
weight(Mean±S.D.)
406 + 63-4
472 ±63-1
97-8 + 8-5
Ovarian
weight(Mean±S.D.)
47-5 + 9-08
50-2 + 5-8
49-3 + 8-9
* Day 1: 100 /ig/rat. Dose increased by 25 /ig every day up to 5th day. Days 6 and 7: 250
//g/rat.
t Days 1 to 3: 0-1 ml/rat/day; Days 4 to 7: 0-3 ml/rat/day.
corpora lutea of the control and the lh antiserum-treated groups did not differ
significantly, the histological examination of the ovaries revealed that the
treated ovaries had smaller corpora lutea with a low degree of luteinization.
The luteal cells of the treated group had sparse cytoplasm which was hyaline
in nature, pycnotic nuclei and a central non-luteinized area. The interstitium
was reduced and non-luteinized, the hilus region being occupied by a highly
vascular bed.
Localization of inhibitory action of LH antiserum
Pilot experiments wherein a single dose of lh antiserum was given each
morning starting from Days 1 to 7 of pregnancy showed that if the antiserum
treatment was started after Day 4 of pregnancy, it had no effect on implanta¬
tion. In order to study the critical time element at which the antiserum was
effective, to one group of rats 0-2 ml of antiserum was administered at 10.00
hours on Day 4 of pregnancy and to another the same volume was administered
at 18.00 hours on the same day. As can be seen from the results presented in
Table 2, administration of antiserum on the evening of the 4th day was not
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effective in inhibiting implantation. It may, however, be noted that, at the
second laparotomy, whereas the group receiving the injection in the morning
continued to show lack of implantation sites, the 4th-day evening group
showed that the 8th-day sites had been secondarily resorbed.
Table 2
localization of inhibitory action of lh antiserum on implantation
Group
I
II
Treatment
0-2 ml antiserum on
Day 4 at 10.00 hours
0-2 ml antiserum on
Day 4 at 18.00 hours
No.
of
rats
8th day
No. of
rats with
sites
No. of
sites(total/ave.)
0/0
27/6-7*
15lh day
No. of
rats with
sites
No. of
sites(total/ave.)
0/0
0/0
* Sites normal in size.
Induction ofdelayed implantation with a 'minimum effective dose' {MED) ofLHantiserum
In the light of the above results it was considered of interest to arrive at an
med of the lh antiserum, which would influence only the implantation process
and not the survival of the implanted blastocyst. The med was established by
administration of 0-1, 0-05 and 0-025 ml of lh antiserum to three groups of
Table 3
delayed implantation with the med of lh antiserum
Group Treatment
No.
of
rats
Laparotomy results
8th day
No. of
rats
with
sites
No. of
sites(total/
ave.)
15th day
No. of
rats
with
sites
No. of
sites(total/
ave.)
20th day
No. of
rats
with
sites
No. of
sites(total/
ave.)
I
II
III
0-1 ml antiserum
0-05 ml antiserum
0-025 ml antiserum
0
1*
2
0/0
2/0-33
17/8-5
0/031/5-16
17/8-5
0
st
2
0/0
25/4-16
17/8-5
* Only one rat showed two sites on 8th day. This showed three additional sites by 20th day.
-f Three rats in this group had resorbed sites. One rat delivered normally and gave birth to
seven viable pups.
rats on Day 4 of pregnancy at 10-00 hours. From the results presented in
Table 3, it can be seen that 0-05 ml was the lowest dose required to inhibit
implantation. The results of the second and third laparotomy, however,
showed that this dose level of antiserum only delayed implantation, a varying
number of new sites appearing at these subsequent laparotomies. Not only did
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the size of the sites differ, showing that the time of implantation of viable
blastocysts was different, but also the fate of implanted blastocysts in the
different animals of this group varied from total to partial résorption by the
20th day, thus altering the average number of sites on this day. It may be of
interest to point out here that, in rats receiving 0-025 ml of the antiserum,
though the number of implantation sites on the 8th day was normal, the size
of each site was about one fourth of the normal. This, however, did not affect
the continued survival of the blastocysts to term.
Mechanism of action of LH: counteraction of effects of LH antiserum by oestradiol-17ß
It was thought likely that administration of lh antiserum to pregnant rats
resulted in inhibition of steroid synthesis, particularly that of oestrogens. The
ability of oestradiol-17/5 to counteract the inhibitory effects of lh antiserum
was, therefore, tested by giving to one group of rats, which had already received
on the 4th-day morning 0-075 ml of lh antiserum, 0-25 µg oestradiol-17/? in
0-1 ml of peanut oil, at 18.00 hours on the same day. The control group
received lh antiserum in the morning of the 4th day and only the oil vehicle
in the evening. As seen from Table 4, oestradiol-17/? was able to reverse the
effect of lh antiserum in all the cases.
Table 4
reversal of lh antiserum inhibition by oestradiol
Group
I
II
Treatment
0-05 ml lh antiserum on
Day 4 at 10.00 hours
0-075 ml lh antiserum
on Day 4 at 10.00 hours
+ 0-25 /ig oestradiol-17ß
at 18.00 hours
No.
of
rats
No. of
rats with
sites
4*
8th day laparotomy :
No. of sites(total¡average)
0/0
30/6-0
* One rat bled profusely on the evening of the 7th day; its uterus was
highly hyperaemic and progestational as seen at laparotomy.
DISCUSSION
It is well known that in the intact rat, pituitary is obligatory for initiating
implantation. Though the earlier attempts ofSchlough, Schuetz & Meyer (1965)
to induce implantation in hypophysectomized rats with ovine pituitary lh
failed, Macdonald, Armstrong & Greep (1967) have recently demonstrated
the ability of 50 µg of ovine lh to induce implantation when administered in a
delaying agent such as bees-wax.
Using specific antigonadotrophins at different dose levels on different days,
we have been able to show here, for the first time, that lh is the only pituitary
gonadotrophin required for implantation in the intact rat. Hayashida & Young
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(1963), however, in a preliminary communication, have also shown that they
could inhibit implantation using a large daily dose of 2 ml of lh antiserum
from Days 1 to 5 of pregnancy.
Accumulated evidence suggests that both progesterone and oestrogen are
essential for implantation, the former maintaining the blastocysts in a viable
condition and bringing about progestational changes in the uterus, the latter
being essential for the implantation process as such. Since Day 4 of pregnancy
is an important marker in the normal pregnancy cycle of the rat, attention has
been focused on the events occurring on that day. Shelesnyak & Kraicer (1963),
on the basis of their own and several others' work, have suggested an oestrogen
surge to occur on the afternoon of Day 4 of pregnancy, which is essential for
implantation on Day 6. Our observations on the effects of lh antiserum
administered at different times on Day 4 and the reversal by oestradiol-17/?
administered on the evening of the same day, would point to an overall control
of oestrogen synthesis by lh and that the surge is initiated before 18.00 hours
of the same day.
It is not surprising that administration of large amounts of antiserum, such
as 0-2 ml in our case or 2-0 ml/day, as used by Hayashida & Young (1963),
would result in total inhibition of both progesterone and oestrogen production.
Thus, we have noticed that, when 0-2 ml of antiserum is given on the evening
of Day 4, though it does not result in inhibition of implantation, the implanted
blastocysts are secondarily resorbed at a later date. The résorption could very
well be due to lack of progesterone essential for the post-implantation survival
of the blastocyst. Similarly, though administration of 0-025 ml of antiserum
on the morning of Day 4 does not result in inhibition of implantation, the
implantation sites tend to be smaller in size when compared with normal ones.
This decrease in size of the sites may be due to the low progesterone titres
present in the antiserum-treated animals. This ability of the antiserum, when
given in the large doses, to affect progesterone synthesis may well explain why
Munshi & Rao (1967) were unable to get implantation in mice treated with
0-2 ml of lh antiserum and 1 ^g of oestradiol-17/? on Day 3 of pregnancy.
These observations prompted us to determine the minimum effective dose
of lh antiserum which, when given on the morning of Day 4, would essentially
block oestrogen biosynthesis and not affect progesterone production to a large
extent. We have thus been able to show that it is possible to delay implantation
by giving as little as 0-05 ml of lh antiserum on the morning of Day 4 to rats
weighing 100 to 150 g. This delayed implantation in the absence of exogenous
progesterone administration would indicate the blocking, mainly, of oestrogen
synthesis at this dose level.
The present investigations suggest that the oestrogen release from the ovary
at mid-day on Day 4 of pregnancy is preceded by an lh surge or release from
the pituitary. The fact that administration of antiserum at 10.00 hours on
Day 4 of pregnancy results in total inhibition of implantation suggests that, at
this time, lh has not yet stimulated oestrogen production. Using a radio-
immunoassay developed in our laboratory, preliminary studies of the lh level
prevailing during the evening of the 3rd day and at 10.00 hours on the 4th
day show that it is significantly higher at the latter hour.
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Note added in the proof: Since different batches of antisera tend to have different
antibody titres, it is essential to determine the med with every fresh batch of
antiserum used. A minimum of 360 to 450 µg of lh specific antibody given on
4th-day morning by subcutaneous route will bring about delayed implantation.
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